Keppra Loading Dose
For adults with normal renal function, administer levetiracetam 60 mg/kg IV (maximum 4,500 mg) as a loading dose for status epilepticus, or 1,500-2,500 mg IV for non-emergent seizure situations.
Status Epilepticus Context
When treating benzodiazepine-refractory status epilepticus, levetiracetam should be dosed at 60 mg/kg IV (maximum 4,500 mg) based on the most recent high-quality evidence 1. The 2024 ACEP Clinical Policy establishes that levetiracetam, fosphenytoin, and valproate have similar efficacy as second-line agents, with approximately 47% of patients achieving seizure cessation and improved consciousness at 60 minutes 1.
The pediatric guidelines for CAR T-cell therapy provide specific weight-based dosing for status epilepticus:
- Loading dose: 40 mg/kg IV (maximum 2,500 mg) for both convulsive and non-convulsive status epilepticus 2
- This is administered as an IV bolus in addition to maintenance dosing
- After resolution, maintenance dosing is 15-30 mg/kg IV every 12 hours depending on the clinical scenario
Non-Emergent Loading
For non-status epilepticus situations requiring rapid therapeutic levels:
- 1,500 mg IV has been studied in elderly patients (≥65 years) with documented efficacy 3
- 2,500 mg IV over 5 minutes has demonstrated safety in refractory seizures 3
- Oral loading with 1,500 mg is well-tolerated and achieves therapeutic concentrations of approximately 30 mcg/mL within 1-2 hours 4
Administration Considerations
Rapid IV push administration of undiluted levetiracetam is safe and well-tolerated for loading doses up to 4,500 mg 5. This allows for faster drug delivery in emergent situations without the need for dilution or prolonged infusion times. The 2009 pediatric study demonstrated safety with loading doses of 20-60 mg/kg administered rapidly with minimal dilution 6.
Dosing Nuances
The evidence shows conflicting results regarding optimal loading dose magnitude:
- A 2026 retrospective study found no difference in seizure termination rates between ≤20 mg/kg, 21-39 mg/kg, and ≥40 mg/kg groups (92.9% vs 89.3% vs 84.7%, p=0.377) 7
- However, the ≥40 mg/kg group had higher intubation rates (45.8% vs 28.2% vs 26.8%, p=0.040) 7
- Another 2026 study found no difference in need for additional antiseizure medications between <40 mg/kg and ≥40 mg/kg groups after adjusting for confounders 8
Despite these mixed findings, the most recent 2024 guideline-level evidence from ACEP supports the 60 mg/kg dosing strategy established in the ESETT trial for benzodiazepine-refractory status epilepticus 1.
Renal Function Considerations
For patients with normal renal function (CrCl >80 mL/min), standard dosing applies without adjustment 9. The FDA label confirms levetiracetam clearance correlates directly with creatinine clearance, with approximately 66% of the drug excreted unchanged in urine 9.
Critical caveat: In critically ill patients with augmented renal clearance (CrCl >130 mL/min), standard doses may be insufficient and higher doses or alternative regimens may be required, though clinical validation is limited 10.
Maintenance Dosing After Loading
Following the loading dose:
- Adults: 500-1,500 mg IV every 12 hours 9
- Pediatric patients (4-16 years): 30 mg/kg every 12 hours (maximum 1,500 mg) 2
- Pediatric patients (6 months-4 years): 25 mg/kg every 12 hours 9
The FDA-approved maintenance dosing can be initiated 12 hours after the loading dose 9.